80 related articles for article (PubMed ID: 32213734)
1. The risk factors for hepatic steatosis in patients with primary aldosteronism.
Shibayama Y; Wada N; Baba S; Obara S; Sakai H; Usubuchi H; Terae S; Nakamura A; Atsumi T
Endocr J; 2020 Jun; 67(6):623-629. PubMed ID: 32213734
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
[TBL] [Abstract][Full Text] [Related]
3. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic Traits.
Brand T; van den Munckhof ICL; van der Graaf M; Schraa K; Dekker HM; Joosten LAB; Netea MG; Riksen NP; de Graaf J; Rutten JHW
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3881-e3889. PubMed ID: 34137897
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism.
Park SS; Ahn CH; Kim SW; Yoon JW; Kim JH
J Clin Endocrinol Metab; 2024 Jan; 109(2):e788-e798. PubMed ID: 37647891
[TBL] [Abstract][Full Text] [Related]
6. Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.
Er LK; Lin MC; Tsai YC; Hsiao JK; Yang CY; Chang CC; Peng KY; Chueh JS; Wu VC;
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32713841
[TBL] [Abstract][Full Text] [Related]
7. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
Spyroglou A; Handgriff L; Müller L; Schwarzlmüller P; Parasiliti-Caprino M; Fuss CT; Remde H; Hirsch A; O'Toole SM; Thuzar M; Petramala L; Letizia C; Deflorenne E; Amar L; Vrckovnik R; Kocjan T; Zhang CD; Li D; Singh S; Katabami T; Yoneda T; Murakami M; Wada N; Inagaki N; Quinkler M; Ghigo E; Maccario M; Stowasser M; Drake WM; Fassnacht M; Bancos I; Reincke M; Naruse M; Beuschlein F
Eur J Endocrinol; 2022 Sep; 187(3):361-372. PubMed ID: 35895721
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
9. Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: a comparison of two different tecniques to evaluate visceral fat distribution.
Stramaglia G; Greco A; Guglielmi G; De Matthaeis A; Vendemiale GL
J Nutr Health Aging; 2010 Jan; 14(1):6-10. PubMed ID: 20082047
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.
Chen Y; Chen X; Chen Q; Yu C
Front Endocrinol (Lausanne); 2021; 12():565714. PubMed ID: 33967948
[TBL] [Abstract][Full Text] [Related]
11. Obesity-Induced Hepatic Steatosis Is Partly Mediated by Visceral Fat Accumulation in Subjects with Overweight/Obesity: A Cross-Sectional Study.
Liu F; Chen S; Li X; Li S; Xiao Y; Han J; Tu Y; Bao Y; Bai W; Yu H
Obes Facts; 2023; 16(2):164-172. PubMed ID: 36257286
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
13. Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism.
Zhang Z; Luo Q; Tuersun T; Wang G; Wu T; Zhang D; Wang M; Zhou K; Sun L; Yue N; Li N
Clin Endocrinol (Oxf); 2021 Jan; 94(1):3-11. PubMed ID: 32810877
[TBL] [Abstract][Full Text] [Related]
14. Unilateral primary aldosteronism as an independent risk factor for vertebral fracture.
Yokomoto-Umakoshi M; Sakamoto R; Umakoshi H; Matsuda Y; Nagata H; Fukumoto T; Ogata M; Ogawa Y;
Clin Endocrinol (Oxf); 2020 Mar; 92(3):206-213. PubMed ID: 31868939
[TBL] [Abstract][Full Text] [Related]
15. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.
Graffy PM; Pickhardt PJ
Br J Radiol; 2016 Jun; 89(1062):20151024. PubMed ID: 26876880
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Yang Y; Reincke M; Williams TA
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
[TBL] [Abstract][Full Text] [Related]
17. Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism.
Haze T; Hatakeyama M; Komiya S; Kawano R; Ohki Y; Suzuki S; Kobayashi Y; Fujiwara A; Saka S; Tamura K; Hirawa N
Hypertens Res; 2021 Oct; 44(10):1341-1351. PubMed ID: 34363052
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Hepatic Steatosis in Adults Presenting to the Emergency Department Identified by Unenhanced Chest CT.
Garg T; Chu LC; Zimmerman SL; Weiss CR; Fishman EK; Azadi JR
Curr Probl Diagn Radiol; 2023; 52(1):35-40. PubMed ID: 36030138
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
[No Abstract] [Full Text] [Related]
20. Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome.
Bu X; Sun F; Zhang H; Liu X; Zhao Z; He H; Li Y; Yan Z; Zhu Z
J Diabetes Res; 2022; 2022():8932133. PubMed ID: 36117521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
